0 %

LAMP Human Hemochromatosis KIT (3 mutations)

The LAMP Human Hemochromatosis 3mut KIT is an in vitro diagnostic test intended for the qualitative detection of the mutations C282Y (rs1800562), H63D (rs1799945) and S65C (rs1800730) on EDTA whole blood and extracted DNA. This assay is dedicated to professional use in diagnostic laboratories. The device is not for self-testing.

Regulatory status: CE-IVD

Format: 24 reactions 

Target gene: HFE

Linked disease: Hereditary hemochromatosis

Mutation: C282Y, H63D, S65C

Method: LAMP + meting curve analysis 

Sample: EDTA whole blood - no DNA extraction required - or extracted DNA

Compatible instruments: LightCycler 480 I&II / Cobas z 480 (Roche); CFX96 / CFX Opus 96 (Bio-Rad); QuantStudio 1/3/5 & 6/7 Flex (Applied Biosystems); MIC qPCR (Bio Molecular Systems); LC-Genie III & Genie HT (Optigene)

Software / result interpretation: Automated genotype calling via GeneFox software; mandatory visual confirmation of the melting curve

Turn around time: < 1h 

General information

Advantages

icon fast
Fast
icon No-DNA-extraction
No DNA extraction
icon comprehensive
Compatible with a variety of qPCR machines
icon easy-to-use
Automatic interpretation of the results

Linked products

LaCar
The LAMP Human Hemochromatosis KIT is an in vitro diagnostic test intended for the qualitative detection of the mutations C282Y (rs1800562) and H63D (rs1799945) on EDTA whole blood and extracted DNA.
Software that helps to interpret the results of LaCAR GPD and pharmacogenetics assays and generates standardised reports.

The LC-HFE3mut-LP kit uses loop-mediated isothermal amplification, a robust amplification method using four to six primers per target, that can be directly used on EDTA whole blood samples, without DNA purification and on extracted DNA samples from whole blood samples.


The genotyping is performed by melting curve analysis after amplification, using a specific probe and quencher for each target SNP.

Test principle

Hereditary Hemochromatosis
Hereditary hemochromatosis (HH) is a recessive genetic disorder characterized by an increased intestinal iron absorption resulting in systemic iron overload, especially in the liver, pancreas, joints and testes. If untreated, HH can cause liver fibrosis, cirrhosis and hepatocellular carcinoma. HH is commonly caused by certain variants in the HFE gene.


C282Y
C282Y (rs1800562; c.845G>A, p. Cys282Tyr) is considered the most relevant mutation responsible for HH.
Carrier frequency: 5-10% in Caucasian populations; incidence of (A;A) homozygotes around 1/200.


H63D
H63D (rs1799945; c.187C>G, p. His63Asp), is implicated in mild iron overload when inherited in the compound homozygous state for H63D or heterozygous state with C282Y/S65C.
Carrier frequency: 3.3%-15.2% in the general population across the world.


S65C
S65C (rs1800730; c.193A>T, p. Ser65Cys) ), is implicated in mild iron overload when inherited in the compound heterozygous state with either C282Y or H63D.
Carrier frequency: 2-3% in Caucasian populations.

Background information

You have a question regarding our products ? You want to know more about our method ?

Find out about our other expertises

Genetic testing CE Kits
Newborn Screening
Genetic testing CE Kits
Pharmacogenetics
Contact